Predictions on future diagnosis and treatment of osteoporosis: results and discussion of a recent opinion poll.
作者信息
Gruber H E, Farley S M, Baylink D J
出版信息
Calcif Tissue Int. 1995 Aug;57(2):83-5. doi: 10.1007/BF00298424.
PMID:7584879
Abstract
摘要
相似文献
1
Predictions on future diagnosis and treatment of osteoporosis: results and discussion of a recent opinion poll.骨质疏松症未来诊断与治疗的预测：近期一项民意调查的结果与讨论
Calcif Tissue Int. 1995 Aug;57(2):83-5. doi: 10.1007/BF00298424.
2
[Osteoporosis: long-term prevention and future treatment. Interview by Robert Henry].[骨质疏松症：长期预防与未来治疗。罗伯特·亨利访谈]
Union Med Can. 1990 Sep-Oct;119(5):242-7.
3
Corticosteroid-induced osteoporosis.糖皮质激素性骨质疏松症
J Am Med Womens Assoc (1972). 1998 Winter;53(1):25-30, 40.
4
Osteoporosis and estrogen deprivation. Experimental approaches to therapy: an overview.
Postgrad Med. 1989 Apr;Spec No:23-5; discussion 33-43.
5
[Involutional osteoporosis--pathogenesis, diagnosis, prevention and therapy].[绝经后骨质疏松症——发病机制、诊断、预防与治疗]
Postepy Hig Med Dosw. 1991;45(1-2):101-17.
6
Management of osteoporosis.骨质疏松症的管理
Dis Mon. 1999 Feb;45(2):21-54. doi: 10.1016/s0011-5029(99)90010-x.
7
[The Future of Osteoporosis Research and Treatment].[骨质疏松症研究与治疗的未来]
Yakugaku Zasshi. 2019;139(1):13-14. doi: 10.1248/yakushi.18-00154-F.
8
Management of osteoporosis.
Adv Intern Med. 1999;44:175-207.
9
Effect of glucocorticoids on bone density.糖皮质激素对骨密度的影响。
Med Pediatr Oncol. 2003 Sep;41(3):212-6. doi: 10.1002/mpo.10339.
10
Do patients receive appropriate information and treatment following bone mineral density measurements?在进行骨密度测量后，患者是否获得了适当的信息和治疗？
Rheumatology (Oxford). 2002 Sep;41(9):1073-4. doi: 10.1093/rheumatology/41.9.1073.
引用本文的文献
1
The bone-building action of the parathyroid hormone: implications for the treatment of osteoporosis.甲状旁腺激素的骨生成作用：对骨质疏松症治疗的启示。
Drugs Aging. 1999 Aug;15(2):117-29. doi: 10.2165/00002512-199915020-00005.
本文引用的文献
1
Assessing value for money in medical screening.评估医学筛查中的性价比。
J Med Screen. 1994 Jan;1(1):39-44. doi: 10.1177/096914139400100108.
2
The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.重组人（1-84）或合成人（1-34）甲状旁腺激素对成年骨质疏松性去卵巢大鼠骨骼的影响。
Endocrinology. 1993 Apr;132(4):1577-84. doi: 10.1210/endo.132.4.8462456.
3
Long-term fracture prediction by bone mineral assessed at different skeletal sites.通过评估不同骨骼部位的骨矿物质进行长期骨折预测。
J Bone Miner Res. 1993 Oct;8(10):1227-33. doi: 10.1002/jbmr.5650081010.
4
Effect of sodium fluoride, calcium, phosphate, and vitamin D2 on trabecular bone balance and remodeling in osteoporotics.氟化钠、钙、磷和维生素D2对骨质疏松症患者小梁骨平衡及重塑的影响。
Bone. 1985;6(5):381-9. doi: 10.1016/8756-3282(85)90337-0.
5
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis.氟化物治疗对绝经后骨质疏松症女性骨折率的影响。
N Engl J Med. 1990 Mar 22;322(12):802-9. doi: 10.1056/NEJM199003223221203.
6
Fluoride therapy for osteoporosis: a review of dose response, duration of treatment, and skeletal sites of action.氟化物治疗骨质疏松症：剂量反应、治疗持续时间及作用骨骼部位的综述
Calcif Tissue Int. 1991;49 Suppl:S64-72. doi: 10.1007/BF02555092.
Zotero 插件